Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |
| Integer Hldg | 1 | 0 | 0 | 0 | €101.00 | - | - |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €74.00 | - | - |
| Davita Inc. | 2 | 0 | 0 | 0 | €138.70 | €124.89 | -9.958% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €285.00 | - | - |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.82 | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | €65.90 | €65.00 | -1.366% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €132.00 | €150.00 | 13.636% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €343.60 | €369.72 | 7.603% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €65.32 | €85.68 | 31.176% |
| Amedisys Inc. | 13 | 0 | 0 | 0 | €84.00 | €92.26 | 9.833% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €11.99 | €22.78 | 89.952% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.30 | €45.10 | 146.421% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €90.50 | €124.85 | 37.953% |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.10 | €23.22 | 28.273% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €214.40 | €247.61 | 15.489% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.40 | - | - |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €102.30 | €110.00 | 7.527% |
| Korian S.A. | 1 | 0 | 1 | 0 | €2.52 | - | - |
| Alkermes plc | 12 | 2 | 1 | 0 | €22.00 | €34.08 | 54.912% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €99.00 | - | - |